WELL HEALTH TECH CORP ORD - WHTCF STOCK NEWS

WELL and HEALWELL AI have launched the second-generation of WELL AI Decision Support (WAIDS) with advanced chronic disease screening capabilities. The tool identifies over 100 diseases and provides actionable clinical insights, aiding in chronic disease management in Canada, which costs an estimated $190 billion annually. The upgraded WAIDS now detects chronic diseases like chronic kidney disease, hypertension, and diabetes, offering risk stratification for patients. Dr. Michael Frankel, Chief Medical Officer of WELL, praised the tool for its effectiveness in providing key disease insights and risk assessments to physicians. HEALWELL AI's technology powers WAIDS, aiming to enhance decision-making in healthcare. The collaboration between WELL and HEALWELL AI continues to leverage data science and innovative technology to transform healthcare.

WELL Health Technologies announced a collaboration with Microsoft to accelerate healthcare's digital transformation. This partnership aims to integrate Microsoft Azure and its AI with WELL's digital health platform to enhance clinical outcomes, optimize costs, ensure data privacy, and improve scalability. The collaboration focuses on modernizing infrastructure, cost optimization, data security, and integrating innovative healthcare solutions through AI technologies. WELL aims to improve patient care, drive operational excellence, and shape the future of healthcare delivery globally.

WELL Health Technologies Corp. supports increased reimbursement rates in Ontario, Alberta, and Manitoba to enhance healthcare delivery. The provinces' investments aim to address inflation challenges and attract skilled physicians, benefiting WELL's clinic growth and organic expansion.

WELL Health Technologies Corp. will release its Fiscal Fourth Quarter and Year End 2023 financial results on March 21, 2024. The conference call will be hosted by Hamed Shahbazi, Chairman and CEO, and Eva Fong, CFO.

WELL Health Technologies Corp. announces significant growth milestones for its subsidiary, OceanMD, with over 4,700 clinics and hospitals and 37,000 active users in Canada. The company saw 78% YoY growth in total sites and 65% YoY growth in active users. Ocean Platform sends over 1.2 million referrals annually, reflecting a 50% YoY increase. The upcoming launch of Health Messenger in Q2-2024 aims to improve healthcare provider-patient communications.

WELL Health Technologies Corp. announces integration update to streamline operations and drive profitable growth. The company restructures its business into three key components overseen by key leaders to enhance synergies and innovation. The PR highlights revenue forecasts, cost optimization programs, and strategic initiatives for growth.

WELL Health Technologies Corp. has announced the creation of a dedicated public sector group to provide support to large scale health systems and care delivery networks in Canada. The company aims to combine and deliver product offerings specifically suited for the public sector's unique scale and requirements, leveraging its operating strengths, including Canada's leading provider-centric technology platform and the largest network of outpatient clinics in the country. WELL has appointed Shane Sabatino as head of public sector partnerships to oversee this division.

WELL Health Technologies Corp. (WELL) has successfully closed the refinancing of a new credit facility for its subsidiary, WELL Health USA. The facility, led by JPMorgan Chase Bank, N.A., includes a primary $175M credit facility with an additional $125M accordion for future growth. The refinanced credit facility matures in three years and carries a floating interest rate. The arrangement enhances WELL USA's financial flexibility, essential for executing its strategic growth plans and maintaining its commitment to financial discipline. The syndicate includes JPMorgan Chase Bank, N.A., CIBC, HSBC Canada, The Bank of Nova Scotia, The Bank of Montreal, and The Export Development Corporation. The CEO, Hamed Shahbazi, expressed gratitude for the support and leadership of the syndicate members.

WELL Health Technologies Corp. expects to announce record quarterly revenue and positive EPS for Q4-2023. The company achieved its 20th consecutive quarter of record quarterly revenue, driven by double-digit YoY organic growth and inorganic growth in both US and Canadian patient visits. The BC clinics achieved a record Net Promoter Score of 80% in Q4-2023 compared to the industry average of 34% for the Canadian healthcare sector. WELL's patient visits and Total Care Interactions metrics are expected to report record revenue for Q4-2023.